Skip to main content
Top
Published in: AIDS and Behavior 3/2015

01-03-2015 | Original Paper

Uptake of HIV Testing in Substance Use Disorder Treatment Programs That Offer On-Site Testing

Authors: Tiffany L. Kyle, Viviana E. Horigian, Susan Tross, Valerie A. Gruber, Margaret Pereyra, Raul N. Mandler, Daniel J. Feaster, Lisa R. Metsch

Published in: AIDS and Behavior | Issue 3/2015

Login to get access

Abstract

Increasing rates of HIV testing within substance use disorder (SUD) treatment clients is an important public health strategy for reducing HIV transmission rates. The present study examined uptake of HIV testing among 1,224 clients in five SUD treatment units that offered on-site testing in Florida, New York, and California. Nearly one-third (30 %) of the participants, who had not previously tested positive, reported not having been tested for HIV within the past 12 months. Women, African Americans, and injection drug users had a higher likelihood of having been tested within the past 12 months. The SUD treatment program was the most frequently identified location of participants’ last HIV test. Despite the availability of free, on-site testing, a substantial proportion of clients were not tested, suggesting that strategies to increase uptake of testing should include addressing barriers not limited to location and cost.
Literature
2.
go back to reference Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.CrossRefPubMed Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.CrossRefPubMed
4.
go back to reference Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010;50(3):85–95.CrossRef Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010;50(3):85–95.CrossRef
5.
go back to reference Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(RR-14):1–17. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(RR-14):1–17.
6.
go back to reference Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893–6.CrossRefPubMed Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893–6.CrossRefPubMed
7.
go back to reference Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas—2010. HIV Surveillance Supplemental Report 2012;17(3), part A. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas—2010. HIV Surveillance Supplemental Report 2012;17(3), part A.
8.
go back to reference Centers for Disease Control and Prevention. Diagnoses of HIV infection and AIDS in the United States and dependent areas, 2009. HIV Surveillance Report 2010, 21. Centers for Disease Control and Prevention. Diagnoses of HIV infection and AIDS in the United States and dependent areas, 2009. HIV Surveillance Report 2010, 21.
9.
go back to reference King KM, Nguyen HV, Kosterman R, Bailey JA, Hawkins JD. Co-occurrence of sexual risk behaviors and substance use across emerging adulthood: evidence for state- and trait-level associations. Addiction. 2012;107(7):1288–96.CrossRefPubMedCentralPubMed King KM, Nguyen HV, Kosterman R, Bailey JA, Hawkins JD. Co-occurrence of sexual risk behaviors and substance use across emerging adulthood: evidence for state- and trait-level associations. Addiction. 2012;107(7):1288–96.CrossRefPubMedCentralPubMed
10.
go back to reference Raj A, Saitz R, Cheng DM. Associations between alcohol, heroin and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse. 2007;33:169–78.CrossRefPubMed Raj A, Saitz R, Cheng DM. Associations between alcohol, heroin and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse. 2007;33:169–78.CrossRefPubMed
11.
go back to reference Rosengard C, Anderson BJ, Stein MD. Correlates of condom use and reasons for condom non-use among drug users. Am J Drug Alcohol Abuse. 2006;32:637–44.CrossRefPubMed Rosengard C, Anderson BJ, Stein MD. Correlates of condom use and reasons for condom non-use among drug users. Am J Drug Alcohol Abuse. 2006;32:637–44.CrossRefPubMed
12.
go back to reference Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012;102(6):1160–7.CrossRefPubMedCentralPubMed Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012;102(6):1160–7.CrossRefPubMedCentralPubMed
13.
go back to reference Abraham AJ, O’Brien LA, Bride BE, Roman PM. HIV/AIDS services in private substance abuse treatment programs. Drug Alcohol Depend. 2011;115(1–2):16–22.CrossRefPubMedCentralPubMed Abraham AJ, O’Brien LA, Bride BE, Roman PM. HIV/AIDS services in private substance abuse treatment programs. Drug Alcohol Depend. 2011;115(1–2):16–22.CrossRefPubMedCentralPubMed
14.
go back to reference Abraham AJ, O’Brien LA, Knudsen HK, Bride BE, Smith GR, Roman PM. Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs. J Subst Abuse Treat. 2012;44(1):120–5.CrossRefPubMedCentralPubMed Abraham AJ, O’Brien LA, Knudsen HK, Bride BE, Smith GR, Roman PM. Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs. J Subst Abuse Treat. 2012;44(1):120–5.CrossRefPubMedCentralPubMed
15.
go back to reference Pollack HA, D’Aunno T. HIV testing and counseling in the nation’s outpatient substance abuse treatment system, 1995–2005. J Subst Abuse Treat. 2010;38(4):307–16.CrossRefPubMed Pollack HA, D’Aunno T. HIV testing and counseling in the nation’s outpatient substance abuse treatment system, 1995–2005. J Subst Abuse Treat. 2010;38(4):307–16.CrossRefPubMed
16.
go back to reference Brown LS Jr, Kritz SA, Goldsmith RJ, et al. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2006;30(4):315–21.CrossRefPubMedCentralPubMed Brown LS Jr, Kritz SA, Goldsmith RJ, et al. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2006;30(4):315–21.CrossRefPubMedCentralPubMed
17.
go back to reference D’Aunno T, Pollack HA, Jiang L, Metsch LR, Friedmann PD. HIV testing in the nation’s opioid treatment programs, 2005–2011: the role of state regulations. Health Serv Res. 2014;49:230–48.CrossRefPubMedCentralPubMed D’Aunno T, Pollack HA, Jiang L, Metsch LR, Friedmann PD. HIV testing in the nation’s opioid treatment programs, 2005–2011: the role of state regulations. Health Serv Res. 2014;49:230–48.CrossRefPubMedCentralPubMed
18.
go back to reference Heimer R, Grau LE, Curtin E, Khoshnood K, Singer M. Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts. Am J Public Health. 2007;97(1):110–6.CrossRefPubMedCentralPubMed Heimer R, Grau LE, Curtin E, Khoshnood K, Singer M. Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts. Am J Public Health. 2007;97(1):110–6.CrossRefPubMedCentralPubMed
19.
go back to reference National Institute of Alcohol Abuse and Alcoholism. NIAAA council approves definition of binge drinking. NIAAA Newslett 2004;3:3. National Institute of Alcohol Abuse and Alcoholism. NIAAA council approves definition of binge drinking. NIAAA Newslett 2004;3:3.
20.
go back to reference Petroll AE, DiFranceisco W, McAuliffe TL, Seal DW, Kelly JA, Pinkerton SD. HIV testing rates, testing locations, and healthcare utilization among urban African-American men. J Urban Health. 2008;86(1):119–31.CrossRefPubMedCentralPubMed Petroll AE, DiFranceisco W, McAuliffe TL, Seal DW, Kelly JA, Pinkerton SD. HIV testing rates, testing locations, and healthcare utilization among urban African-American men. J Urban Health. 2008;86(1):119–31.CrossRefPubMedCentralPubMed
21.
go back to reference Schackman BR, Metsch LR, Colfax GN. The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial. Drug Alcohol Depend. 2012;128(1–2):90–7.PubMedCentralPubMed Schackman BR, Metsch LR, Colfax GN. The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial. Drug Alcohol Depend. 2012;128(1–2):90–7.PubMedCentralPubMed
22.
go back to reference Farnham PG, Holtgrave DR, Sansom SL, Hall HI. Medical costs averted by HIV prevention efforts in the United States, 1991–2006. J Acquir Immune Defic Syndr. 2010;54:565–7.CrossRefPubMed Farnham PG, Holtgrave DR, Sansom SL, Hall HI. Medical costs averted by HIV prevention efforts in the United States, 1991–2006. J Acquir Immune Defic Syndr. 2010;54:565–7.CrossRefPubMed
23.
go back to reference Jain S, Loman ES, Kessler A, et al. Seroprevalence study using oral rapid HIV testing in a large urban emergency department. J Emerg Med. 2012;43(5):269–75.CrossRef Jain S, Loman ES, Kessler A, et al. Seroprevalence study using oral rapid HIV testing in a large urban emergency department. J Emerg Med. 2012;43(5):269–75.CrossRef
24.
go back to reference Cunningham CO, Doran B, DeLuca J, Dyksterhouse R, Asgary R, Sacajiu G. Routine opt-out HIV testing in an urban community health center. AIDS Patient Care STDS. 2009;23(8):619–23.CrossRefPubMedCentralPubMed Cunningham CO, Doran B, DeLuca J, Dyksterhouse R, Asgary R, Sacajiu G. Routine opt-out HIV testing in an urban community health center. AIDS Patient Care STDS. 2009;23(8):619–23.CrossRefPubMedCentralPubMed
25.
go back to reference Christopoulos KA, Weiser SD, Koester KA, et al. Understanding patient acceptance and refusal of HIV testing in the emergency department. BMC Public Health. 2012;3(12):3.CrossRef Christopoulos KA, Weiser SD, Koester KA, et al. Understanding patient acceptance and refusal of HIV testing in the emergency department. BMC Public Health. 2012;3(12):3.CrossRef
27.
go back to reference Haynes LF, Calsyn DA, Tross S. Addressing sexual issues in addictions treatment. Counselor. 2008;9(4):28–36. Haynes LF, Calsyn DA, Tross S. Addressing sexual issues in addictions treatment. Counselor. 2008;9(4):28–36.
28.
go back to reference Pope K, Sonne J, Greene B. What therapists don’t talk about and why understanding taboos that hurt us and our clients. Washington, DC: American Psychological Association; 2006.CrossRef Pope K, Sonne J, Greene B. What therapists don’t talk about and why understanding taboos that hurt us and our clients. Washington, DC: American Psychological Association; 2006.CrossRef
Metadata
Title
Uptake of HIV Testing in Substance Use Disorder Treatment Programs That Offer On-Site Testing
Authors
Tiffany L. Kyle
Viviana E. Horigian
Susan Tross
Valerie A. Gruber
Margaret Pereyra
Raul N. Mandler
Daniel J. Feaster
Lisa R. Metsch
Publication date
01-03-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0864-2

Other articles of this Issue 3/2015

AIDS and Behavior 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.